ALDOSTERONE ANTAGONISTS IN CLINICAL MEDICINE1978; EXCERPTA MED., INTERNATION. CONGR. SER.; NLD; DA. 1978; NO 460; PP. 1-527; BIBL. DISSEM.Conference Paper

INTOXICATION A LA GLYCYRRHIZINE CHEZ UN CIRRHOTIQUE. INEFFICACITE DU TRAITEMENT ANTIALDOSTERONIQUE AU COURS D'UNE DECOMPENSATION OEDEMATO-ASCITIQUEAUDHUY B; PINGET M; DORNER M et al.1980; J. MED. STRASBOURG; FRA; DA. 1980; VOL. 11; NO 6; PP. 330-331; BIBL. 5 REF.Article

EFFECT OF SPIROLACTONE TREATMENT ON THE RENIN-ALDOSTERONE SYSTEM DURING PREGNANCYLAMMINTAUSTA R; ERKKOLA R.1979; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; DEU; DA. 1979; VOL. 17; NO 7; PP. 294-298; BIBL. 30 REF.Article

ACTION DES SPIROLACTONES SUR LE METABOLISME SURRENALIENAUBRY MARAIS FLORENCE.1979; ; FRA; DA. 1979; 114 P.; 30 CM; BIBL. 7 P.; TH. UNIV.: SCI/PARIS 6/1979Thesis

FATAL HYPERKALEMIA AND HYPERCHLOREMIC ACIDOSIS: ASSOCIATION WITH SPIRONOLACTONE IN THE ABSENCE OF RENAL IMPAIRMENTFEINFELD DA; CARVOUNIS CP.1978; J.A.M.A.; USA; DA. 1978; VOL. 240; NO 14; PP. 1516; BIBL. 10 REF.Article

LES INHIBITEURS DE L'ALDOSTERONEVIGY M.1978; CONCOURS MED.; FRA; DA. 1978; VOL. 100; NO 45; PP. 7535-7540Article

PLASMA CORTICOSTEROID CONCENTRATIONS DURING SPIRONOLACTONE ADMINISTRATION: EVIDENCE FOR ADRENAL BIOSYNTHETIC BLOCKADE IN MANTUCK ML; SOWERS JR; FITTINGOFF DB et al.1981; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1981; VOL. 52; NO 6; PP. 1057-1061; BIBL. 28 REF.Article

LE MECANISME D'ACTION D'UN HYPOTENSEUR ETUDIE PAR L'ANALYSE DU CAROTIDOGRAMME: APPLICATION AUX ANTIALDOSTERONESMEYER HEINE A; ANSQUER JC; HAYOUN C et al.1981; THERAPIE; ISSN 0040-5957; FRA; DA. 1981; VOL. 36; NO 6; PP. 623-630; ABS. ENG; BIBL. 12 REF.Article

A STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF SPIROLACTONES: CONTRIBUTION OF THE CYCLOPROPANE RING TO ANTIMINERALOCORTICOID ACTIVITYCHINN LJ; SALAMON KW; DESAI BN et al.1981; J. MED. CHEM.; ISSN 0022-2623; USA; DA. 1981; VOL. 24; NO 9; PP. 1103-1107; BIBL. 14 REF.Article

UTILISATION DE CANRENOATE DE POTASSIUM, ANTAGONISTE DE L'ALDOSTERONE CHEZ LES MALADES ATTEINTS D'INSUFFISANCE CARDIO-VASCULAIRE CHRONIQUESIDORENKO BA; KUDISOV YU M; ROSSEL'S AN et al.1979; KARDIOLOGIJA; SUN; DA. 1979; VOL. 19; NO 3; PP. 41-46; ABS. ENG; BIBL. 8 REF.Article

ALDOSTERONE ET ANTIALDOSTERONES.1978; REV. MED.; FR.; DA. 1978; VOL. 19; NO 1-2; PP. 5-42; ABS. ANGL.; BIBL. DISSEM.Article

EFFECT OF SPIRONOLACTONE ON ANDROGEN-DEPENDENT PROTEINS IN THE VENTRAL PROSTATE OF THE RATCARTER DB; SILVERBERG AB; HARRIS SE et al.1980; J. ENDOCRINOL.; ISSN 0022-0795; GBR; DA. 1980; VOL. 86; NO 3; PP. 471-476; (10 P.); BIBL. 17 REF.Article

REMISION DEL SINDROME NEFROTICO CON CAMBIOS MINIMOS MEDIANTE ESPIRONOLACTONA = REMISSION DU SYNDROME NEPHROTIQUE AVEC MODIFICATIONS MINIMES AU MOYEN DE LA SPIRONOLACTONEMARCO FRANCO JE; ALARCON ZURITA A; PIZA BUNOLA C et al.1979; REV. CLIN. ESP.; ESP; DA. 1979; VOL. 155; NO 1; PP. 63-65; BIBL. 48 REF.Article

MODES OF ACTION OF DIURETICSHIERHOLZER K.1978; CONTRIB. NEPHROL.; CHE; DA. 1978; VOL. 14; NO 111-117; BIBL. 10 REF.Article

SPIROMOLACTONE INDUCED GYNECOMASTIA. A CASE REPORT.GREENLAW C.1977; DRUG INTELLIG. CLIN. PHARM.; U.S.A.; DA. 1977; VOL. 11; NO 2; PP. 70-73; BIBL. 45 REF.Article

STEROIDS.GREEN MJ.1976; ANNU. REP. MEDICIN. CHEM.; U.S.A.; DA. 1976; VOL. 11; PP. 149-157; BIBL. 2 P.Article

DOSE-RESPONSE RELATIONSHIP FOR SPIRONOLACTONE AT STEADY STATEMCINNES GT; PERKINS RM; SHELTON JR et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 3; PP. 317-323; BIBL. 34 REF.Article

TREATMENT OF HIRSUTISM WITH SPIRONOLACTONECUMMING DC; YANG JC; REBAR RW et al.1982; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 247; NO 9; PP. 1295-1298; BIBL. 20 REF.Article

THE POTENCY OF PRORENOATE POTASSIUM RELATIVE TO SPIRONOLACTONE AT STEADY-STATE IN MANMCINNES GT; SHELTON JR; HARRISON IR et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 11; NO 1; PP. 114P-116P; BIBL. 8 REF.Article

SPIRONOLATTONE ED IRSUTISMO FEMMINILE. OSSERVAZIONI PRELIMINARI = SPIRONOLACTONE ET HIRSUTISME OBSERVATION PRELIMINAIREMESSINA M; GARIONE I; MOLINATTI GM et al.1979; MINERVA ENDOCRINOL.; ITA; DA. 1979; VOL. 4; NO 1; PP. 31-35; ABS. ENG; BIBL. 16 REF.Article

CANRENONE - THE PRINCIPAL ACTIVE METABOLITE OF SPIRONOLACTONE.RAMSAY LE; SHELTON JR; WILKINSON D et al.1976; BRIT. J. CLIN. PHARMACOL.; G.B.; DA. 1976; VOL. 3; NO 4; PP. 607-612; BIBL. 20 REF.Article

EFFECT OF ALDOSTERONE ANTAGONISTS ON MINERALCORTICOID SYNTHESIS IN VITRO. INHIBITION OF ALDOSTERONE PRODUCTION BY PRORENOATE-KNETCHITAILO P; DELARUE C; PERROTEAU I et al.1982; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1982; VOL. 77; NO 4-5; PP. 243-249; BIBL. 19 REF.Article

DISTRIBUTION COEFFICIENTS AND IN VITRO HUMAN SERUM PROTEIN BINDING OF SPIRONOLACTONE AND ITS 7ALPHA -CARBOXYMETHYL ANALOGNG AS; KLUZA RB; NEWTON DW et al.1980; J. PHARM. SCI.; USA; DA. 1980; VOL. 69; NO 1; PP. 30-32; BIBL. 20 REF.Article

NEW THERAPEUTIC APPROACH TO THE HIRSUTE PATIENTBOISSELLE A; TREMBLAY RR.1979; FERTIL. STERIL., INT. ED.; USA; DA. 1979; VOL. 32; NO 9-10; PP. 276-279; BIBL. 18 REF.Article

BEHANDLUNG DER DEKOMPENSIERTEN, HYDROPISCHEN HERZINSUFFIZIENZ MIT ETOZOLIN IN KOMBINATION MIT SPIRONOLACTON = TRAITEMENT DE L'INSUFFISANCE CARDIAQUE DECOMPENSEE, HYDROPIQUE PAR L'ETOZOLIN ASSOCIE A LA SPIRONOLACTONEKOPP H.1979; THERAPIEWOCHE; DEU; DA. 1979; VOL. 29; NO 25; PP. 4327-4334; (7 P.); BIBL. 20 REF.Article